From the Journals

Weight Loss Drugs Reshape Facial Surgery: Survey

AAFPRS survey reveals GLP-1 medications drive 50% increase in fat-grafting procedures as patients seek solutions for weight loss-related facial volume loss.

Share

  • 1

    Survey highlights increased fat grafting-procedures due to volume loss related to glucagon-like peptide-1 medications.

  • 2

    Trend toward younger facelift patients and increased treatment seeking for menopause-related concerns.

  • 3

    Regenerative medicine, including platelet-rich plasma and exosome-based therapies, anticipated for growth.

Original Source(s)

Weight Loss Drugs Reshape Facial Surgery: Survey

AAFPRS survey reveals GLP-1 medications drive 50% increase in fat-grafting procedures as patients seek solutions for weight loss-related facial volume loss.

  • by Kerri Miller

  • February 10, 2025

  • 2 min

Related Content

GLP-1 RAs Linked to Higher Hair Loss Risk

A large matched cohort study quantifies the association between glucagon-like peptide-1 receptor agonist use and nonscarring alopecia

Backed by Science: The data behind the Lumify Eye Illuminations portfolio

PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.

  • March 1, 2024

  • 3 min
Education for Gen Alpha and Z on Social Media and Cosmetic Dermatology Trends